Single year dengue simulation results.

Various fractions of the population (0%, 30%, 50%, and 70%) from 2 to 14 years old or from 2 to 46 years old were pre-vaccinated and fifty simulations were run per scenario. The vaccine protects 70% of vaccinees against infection. The averages and standard deviations of the numbers of infections, symptomatic infections (cases of uncomplicated dengue fever), severe cases requiring hospitalization, and vaccinations per 100,000 individuals from fifty stochastic simulations per scenario are reported. Also reported are the average numbers of hospitalizations averted per 100,000 vaccinations.

针对2至14岁或2至46岁的人群，分别以0%、30%、50%、70%的接种比例完成预接种；每种场景下均开展50次随机模拟。该疫苗可为70%的接种者提供感染防护。本数据集报告了每种场景下50次随机模拟的结果，涵盖每10万人口的感染人数、有症状感染病例（即无并发症登革热病例）、需住院治疗的重症病例数以及疫苗接种数的均值与标准差。此外，本数据集同时报告了每10万剂疫苗所避免的住院人次均值。